CRO

The CRO (Contract Research Organization) theme covers companies providing outsourced R&D and clinical development services to biopharma. Core tracks include discovery and preclinical testing, clinical trial operations and site management, data management/biostatistics, regulatory and pharmacovigilance, and central lab services.The sector's total market cap is 298.49 billion HKD, with a 24h change of +0.03%. Among 9 constituents, 7 are up (77.78%) and 2 are down (22.22%). The top gainer is VIVA BIOTECH (01873), with a 24h increase of +5.69%.Tone firm with improving breadth and quality leadership. Trade leaders near term; add selectively in sync with earnings cadence and rate trends.